Is the conclusion that Cytodyn can meet all the criteria to uplist to NASDAQ since our share price has been over $4.00 long enough now???
(4)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.